Augmented Reality Vision for Surgery
The status, timeline and source of this project. A free account opens every field.
Source: EU Funding & Tenders Portal
On European scale, out of an estimated 3.45 million new cases of cancer, the most common sites are female breast, colon, lung and prostate. These four cancers represent half of the overall burden of cancer in Europe, with an economic impact estimated over 125 billion euros. With a potential of global implementation, Trivisio's ARVisS system range will provide more accessible, yet strongly improved
- Status
- Closed
- Sector
- Hospital, Bridge
- Location
- Germany
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Augmented Reality Vision for Surgery
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | ended |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | On European scale, out of an estimated 3.45 million new cases of cancer, the most common sites are female breast, colon, lung and prostate. These four cancers represent half of the overall burden of cancer in Europe, with an economic impact estimated over 125 billion euros. With a potential of global implementation, Trivisio's ARVisS system range will provide more accessible, yet strongly improved, accuracy, completeness and time efficiency in the surgical management of the common, high incidence, malignant cancer tissues. A novel approach is proposed implementing advanced microscopy, in combination with real-time fluorescence and 3D, in-sight image guidance by pre- and intraoperative diagnostic data. Bringing these three main benefits in a straightforward, easy-to-use fashion to the practicing surgeons, the proposed medical device has the potential to bridge the current gap between traditional surgical glass loupes with external information and high standard microscopy devices. Realization of this challenge is possible when Trivisio’s leading know-how and available state-of-the-art technologies, such as augmented reality and optical see-through head-mounted displays, are integrated in a simplified resection tool for healthcare. Higher success rates, time efficiency and subsequent financial cost of more common surgical interventions can then be achieved at only 25% of the current investment budget. Higher survival chances are aimed at by the decrease of post-operative side effects and a reduced cancer recurrence, leading to a lowering of the financial pressure on both medical institutions and national health care systems. |
Location
Country | Germany |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital, Bridge |
Article published date | 2026-01-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Germany
- Boehringer Ingelheim’s New Tablet Production Facility, Ingelheim
- Hameln Pharma Sterile Facility
- Takeda Pharmaceutical Manufacturing Facility, Oranienburg
- Merck Serono Biopharmaceutical R&D Facility Expansion, Darmstadt
- Evonik’s Pharmaceutical Lipids Manufacturing Facility, Hanau, Germany
- Wacker Chemie Biologics Production Facility
- Boehringer Ingelheim Biologicals Development Centre (BDC), Biberach, Germany
- Haupt Pharma, New Packaging Line
